Finally, to explore whether the association between high cancer cell levels of PD-L2 and PFS was related to hormone treatment, we evaluated PD-L2 separately within subgroups of ER+ patients who did or did not receive hormonal treatment. Here, PDCD1LG2 is linked to cancer.